Sabra Health Care REIT, Inc. (SBRA)
| Market Cap | 5.35B +12.1% |
| Revenue (ttm) | 924.30M +23.7% |
| Net Income | 71.51M -59.2% |
| EPS | 0.28 -61.3% |
| Shares Out | 261.96M |
| PE Ratio | 72.57 |
| Forward PE | 29.22 |
| Dividend | $1.20 (5.87%) |
| Ex-Dividend Date | Nov 13, 2026 |
| Volume | 2,327,184 |
| Open | 20.26 |
| Previous Close | 20.26 |
| Day's Range | 20.22 - 20.48 |
| 52-Week Range | 17.54 - 22.77 |
| Beta | 0.64 |
| Analysts | Buy |
| Price Target | 22.71 (+11.11%) |
| Earnings Date | Nov 2, 2026 |
About SBRA
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Financial Performance
In 2025, Sabra Health Care REIT's revenue was $775.76 million, an increase of 10.41% compared to the previous year's $702.64 million. Earnings were $155.61 million, an increase of 22.81%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for SBRA stock is "Buy." The 12-month stock price target is $22.71, which is an increase of 11.11% from the latest price.
News
Sabra Health Care price target raised to $22 from $20 at UBS
UBS raised the firm’s price target on Sabra Health Care (SBRA) to $22 from $20 and keeps a Neutral rating on the shares.
Sabra Health Care REIT, Inc., to Attend Nareit's REITworld 2026 Annual Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #NAREIT--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the com...
Sabra Health Care REIT Earnings Call Transcript: Q3 2026
Q3 normalized FFO and AFFO per share each grew 8% YoY, while SHOP same-store cash NOI rose 14.6%. Guidance was raised, and investment activity continued to expand the SHOP platform.
Sabra Health Care REIT Earnings release: Q3 2026
Sabra Health Care REIT released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Sabra Health Care REIT Quarterly report: Q3 2026
Sabra Health Care REIT has published its Q3 2026 quarterly earnings report on November 3, 2026.
Sabra Health Care REIT Slides: Q3 2026
Sabra Health Care REIT has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2026. T...
Sabra Health Care REIT Slides: Investor presentation
Sabra Health Care REIT has posted slides in relation to its latest quarterly earnings report, which was published on November 2, 2026.
Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 third quarter earnings release on November 2, 2026, after the c...
Discovery Senior Living Acquires Sunshine Retirement Living, Expanding National Operating Platform and Establishing Strategic Pacific Northwest Presence
Acquisition Adds 33 Communities, +3,500 Units Under Management, Brings an Established Operating Team, New Capital Relationships and Regional Growth Opportunities Bonita Springs, Florida--(Newsfile Cor...
Sabra Health Care price target lowered to $21 from $23 at Wells Fargo
Wells Fargo lowered the firm’s price target on Sabra Health Care (SBRA) to $21 from $23 and keeps an Overweight rating on the shares. Discussing earnings for the group, the…
Sabra Health Care price target lowered to $20 from $21 at UBS
UBS analyst Michael Goldsmith lowered the firm’s price target on Sabra Health Care (SBRA) to $20 from $21 and keeps a Neutral rating on the shares.
Sabra Health Care price target lowered to $21 from $23 at Barclays
Barclays analyst Richard Hightower lowered the firm’s price target on Sabra Health Care (SBRA) to $21 from $23 and keeps an Equal Weight rating on the shares. The firm adjusted…
Sabra Health Care initiated with an Outperform at Huntington
Huntington initiated coverage of Sabra Health Care (SBRA) with an Outperform rating and $23 price target Sabra can deliver solid earnings growth through improving core skilled nursing facility fundame...
Sabra Health Care initiated with an Outperform at Huntington
Huntington initiated coverage of Sabra Health Care (SBRA) with an Outperform rating and $23 price target
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the com...
Sabra Health Care REIT Slides: Investor presentation
Sabra Health Care REIT has posted slides in relation to its latest quarterly earnings report, which was published on September 9, 2026.
Sabra Health Care price target raised to $21 from $20 at Mizuho
Mizuho raised the firm’s price target on Sabra Health Care (SBRA) to $21 from $20 and keeps a Neutral rating on the shares.
Sabra Health Care price target raised to $23 from $21 at Barclays
Barclays analyst Richard Hightower raised the firm’s price target on Sabra Health Care (SBRA) to $23 from $21 and keeps an Equal Weight rating on the shares. The firm adjusted…
Sabra Health Care upgraded to Market Perform from Underperform at Raymond James
Raymond James analyst David Rodgers upgraded Sabra Health Care (SBRA) to Market Perform from Underperform without a price target The company’s preannounced tenant and operator transitions “offered a s...
Sabra Health Care REIT Earnings Call Transcript: Q2 2026
Second quarter results showed strong sequential and year-over-year growth in managed senior housing, with robust investment activity and a healthy pipeline. Leverage improved to 4.61x, and 2026 guidance was reaffirmed, projecting 7–8% normalized FFO/AFFO growth.
Sabra Health Care REIT Earnings release: Q2 2026
Sabra Health Care REIT released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Sabra Health Care REIT Quarterly report: Q2 2026
Sabra Health Care REIT has published its Q2 2026 quarterly earnings report on August 4, 2026.
Sabra Health Care REIT Slides: Q2 2026
Sabra Health Care REIT has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. ...